Dentsply Sirona (XRAY) — insider trading
Health Care · NASDAQ
Dentsply Sirona (XRAY) has 30 reported SEC Form 4 insider transactions in our data, including 6 open-market purchases among the most recent 30 (latest 2026-09-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | MAZELSKY JONATHAN JAY | Director | Grant / award / vesting (derivative) | 3,323 | $9.03 | $30.0K | Form 4 |
| 2026-08-10 | Fortson John C. | Officer (EVP & CFO) | Grant / award / vesting (derivative) | 104,200 | — | $0 | Form 4 |
| 2026-08-10 | Fortson John C. | Officer (EVP & CFO) | Grant / award / vesting | 24,014 | — | $0 | Form 4 |
| 2026-08-07 | Frohning Andrea L. | Officer (SVP, CHRO) | Shares withheld for taxes / exercise cost | 802 | $12.12 | $9.7K | Form 4 |
| 2026-06-30 | MAZELSKY JONATHAN JAY | Director | Grant / award / vesting (derivative) | 2,842 | $10.56 | $30.0K | Form 4 |
| 2026-06-15 | HOSEIN CLYDE | Director | Open-market purchase | 6,500 | $9.99 | $64.9K | Form 4 |
| 2026-06-15 | Gladden Brian T | Director | Open-market purchase | 9,985 | $10.02 | $100.0K | Form 4 |
| 2026-06-12 | MAZELSKY JONATHAN JAY | Director | Open-market purchase | 10,000 | $10.14 | $101.4K | Form 4/A |
| 2026-06-12 | MAZELSKY JONATHAN JAY | Director | Grant / award / vesting | 10,000 | $10.14 | $101.4K | Form 4 |
| 2026-06-12 | MCKEON BRIAN P | Director | Open-market purchase | 10,000 | $10.12 | $101.2K | Form 4 |
| 2026-06-11 | Barber Michael J | Director | Open-market purchase | 15,175 | $9.89 | $150.0K | Form 4 |
| 2026-06-11 | HOLDEN BETSY D | Director | Open-market purchase | 10,086 | $9.88 | $99.7K | Form 4 |
| 2026-06-03 | Barber Michael J | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | Forbes James D | Director | Grant / award / vesting | 28,887 | — | $0 | Form 4 |
| 2026-06-03 | Gladden Brian T | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | HOLDEN BETSY D | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | HOSEIN CLYDE | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | MAZELSKY JONATHAN JAY | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | MCKEON BRIAN P | Director | Grant / award / vesting | 28,887 | — | $0 | Form 4 |
| 2026-06-03 | VARON LESLIE F | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | Vergis Janet S. | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | Zurbay Donald | Director | Grant / award / vesting | 22,822 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Bona fide gift (derivative) | 10,900 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Bona fide gift (derivative) | 10,900 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Grant / award / vesting (derivative) | 10,900 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Bona fide gift | 38,382 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Bona fide gift | 38,382 | — | $0 | Form 4 |
| 2026-06-03 | LUCIER GREGORY T | Director | Grant / award / vesting | 38,382 | — | $0 | Form 4 |
| 2026-05-22 | Scavilla Daniel T | Director, Officer (President, CEO & Member of BOD) | Shares withheld for taxes / exercise cost | 4,095 | $10.21 | $41.8K | Form 4 |
| 2026-03-31 | MAZELSKY JONATHAN JAY | Director | Grant / award / vesting (derivative) | 2,645 | $11.34 | $30.0K | Form 4 |
Ask the chat about XRAY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Dentsply Sirona (XRAY).
Last updated 2026-09-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.